News
Despite current headwinds like tariffs and patent expirations, I see long-term opportunity in top-tier pharmaceutical stocks ...
3h
OpenSecrets on MSNPharma industry and Ballard Partners dominate the lobbying space in second quarter of 2025OpenSecrets reports the pharma industry led lobbying in Q2 2025, spending $105.4 million, followed by Ballard Partners at $20 ...
Nomura’s June 2025 analysis shows Indian pharma majors like Sun Pharma, Dr. Reddy’s, Cipla, Lupin, and Zydus posting strong ...
17h
Vietnam Investment Review on MSNCathay Cargo delivers temperature-sensitive pharma shipments in VietnamCathay Pharma has emerged as a specialised logistics solution tailored to meet the rigorous demands of the healthcare and ...
Trump has unveiled a number of moves aimed at cutting drug prices in recent months, but he has yet to move the needle on ...
Plus more pharma news from the Pharmalittle newsletter.
Thermoplastic elastomers (TPE) offer a PFAS-free solution for stoppers in parenteral packaging, ensuring a safer and more ...
FOPE with CIPI team-ups with DCGI to foster dialogue and bolster collaboration with pharma sector: Our Bureau, Bengaluru Monday, August 11, 2025, 13:30 Hrs [IST] Federation of Pha ...
WeightWatchers is now only offering Wegovy while other telehealth providers defiantly hang on to compounded alternatives.
Elias Zerhouni tells Chemistry World what's changed from when he was appointed by a Republican president to the current Trump ...
As tariffs on drug imports from the EU look set to alter pricing and manufacturing strategies, each entity needs to study its full impact.
StockStory.org on MSN17h
Reflecting On Branded Pharmaceuticals Stocks’ Q2 Earnings: Royalty Pharma (NASDAQ:RPRX)As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results